NYSE - Delayed Quote USD

Braskem S.A. (BAK)

Compare
3.8000 -0.0400 (-1.04%)
At close: December 27 at 4:00:02 PM EST
3.8799 +0.08 (+2.10%)
After hours: 8:00:00 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 21.27B
Earnings -593M
Q4'23
Q1'24
Q2'24
Q3'24
0
5B
10B
15B
20B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

6.50
8.82 Average
3.8000 Current
10.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1--12
Avg. Estimate -0.290-2.820.11
Low Estimate -0.290-2.820.09
High Estimate -0.290-2.820.14
Year Ago EPS -0.46-0.67-1.76-2.82

Revenue Estimate

Currency in BRL Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 4--1111
Avg. Estimate 19.9B--79.25B85.84B
Low Estimate 18.57B--76.18B73.95B
High Estimate 21.66B--89.63B100.23B
Year Ago Sales 16.69B--70.57B79.25B
Sales Growth (year/est) 19.23%--12.31%8.31%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. -0.55-0.56-0.17--
EPS Actual -0.46-0.67-1.52-0.24
Difference 0.09-0.11-1.35--
Surprise % 16.48%-19.34%-797.21%--

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate -0.290-2.820.11
7 Days Ago -0.260-2-0.05
30 Days Ago -0.260-2-0.05
60 Days Ago -0.260-2-0.05
90 Days Ago -0.10-1.410.01

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days ------1
Up Last 30 Days ------1
Down Last 7 Days ----1--
Down Last 30 Days ----1--

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
BAK 35.44%---59.73%104.04%
S&P 500 5.00%12.00%2.10%12.20%

Upgrades & Downgrades

Upgrade UBS: Neutral to Buy 9/18/2024
Maintains JP Morgan: Neutral to Neutral 9/10/2024
Upgrade Citigroup: Neutral to Buy 8/20/2024
Maintains JP Morgan: Neutral to Neutral 5/24/2024
Downgrade JP Morgan: Overweight to Neutral 7/5/2023
Upgrade Scotiabank: Sector Perform to Sector Outperform 5/8/2023

Related Tickers